41 – 50 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Ischaemic brain damage after cardiac arrest and induced hypothermia-a systematic description of selective eosinophilic neuronal death. A neuropathologic study of 23 patients.
(
- Contribution to journal › Article
-
Mark
EXPRESS study shows significant regional differences in 1-year outcome of extremely preterm infants in Sweden
(
- Contribution to journal › Article
-
Mark
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
(
- Contribution to journal › Article
-
Mark
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study
(
- Contribution to journal › Article
-
Mark
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo.
(
- Contribution to journal › Article
- 2013
-
Mark
EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases
(
- Contribution to journal › Article
-
Mark
Neurodevelopmental Outcome in Extremely Preterm Infants at 2.5 Years After Active Perinatal Care in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
Staging of Lewy-related pathology in dementia
(
- Contribution to journal › Article
- 2011
-
Mark
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
(
- Contribution to journal › Article
-
Mark
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
(
- Contribution to journal › Article